Rare Disease Drugs Research
9 comprehensive market analysis studies and research reports on the Rare Disease Drugs sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 102 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Monkeypox Vaccine and Treatment Market
CAGR: 10.1%
Study Period : 2021 - 2030
Healthcare
Categories
Healthcare
Categories
Filters and Sort
Showing 9 of 9 results in Rare Disease Drugs
Orphan Drugs Market
CAGR: 6.24%
Study Period : 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Takeda Pharmaceuticals, Novartis, Johnson & Johnson, Roche, Bristol-Myers Squibb
Alpha Mannosidosis Market
CAGR: 16.40%
Study Period : 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Chiesi Farmaceutici, Sobi, Orchard Therapeutics plc, Avrobio, Ultragenyx Pharmaceutical Inc.
Hypoparathyroidism Treatment Market
CAGR: 4%
Study Period : 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Roche, Teva Pharmaceutical Industries, Amgen, Zhejiang NHU, EnteraBio Ltd.
Monkeypox Vaccine and Treatment Market
CAGR: 10.1%
Study Period : 2021 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Bavarian Nordic, SIGA Technologies, Chimerix
Neuromyelitis Optica Spectrum Disorder Market
CAGR: 6.31%
Study Period : 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific
Major Players:Roche, TG Therapeutics, Opexa Therapeutics, Mitsubishi Tanabe Pharma, Horizon Therapeutics
Rare Disease Treatment Market
CAGR: 11.93%
Study Period : 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, South America, Middle East and Africa
Major Players:Amgen, Biomarin Pharmaceutical, Bayer, Bristol-Myers Squibb, AstraZeneca
Rare Neurological Disease Treatment Market
CAGR: 8.60%
Study Period : 2021 - 2030
Regions Covered: North America, Europe, Asia Pacific, South America, Middle East and Africa
Major Players:CSL Behring, Merz Pharma, Kedrion Biopharma, US WorldMeds, Aquestive Therapeutics
Guillain-Barre Syndrome Market
CAGR: 5.77%
Study Period : 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:CSL Behring, Takeda Pharmaceuticals, Grifols, Kedrion Biopharma, Octapharma
Scleroderma Therapeutics Market
CAGR: 7.79%
Study Period : 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Boehringer Ingelheim, Roche, Johnson & Johnson Services Inc. (Actelion), Bayer, Novartis
Yay! You have seen it all
Countries
- Australia Rare Disease Drugs Research
- Canada Rare Disease Drugs Research
- China Rare Disease Drugs Research
- France Rare Disease Drugs Research
- Germany Rare Disease Drugs Research
- India Rare Disease Drugs Research
- Italy Rare Disease Drugs Research
- Japan Rare Disease Drugs Research
- Mexico Rare Disease Drugs Research
- South Korea Rare Disease Drugs Research
- Spain Rare Disease Drugs Research
- UK Rare Disease Drugs Research
- US Rare Disease Drugs Research
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
